Malaria Genomics, Vaccine Development, and Microbiome

被引:2
|
作者
Su, Xinzhuan [1 ]
Stadler, Rachel V. [1 ]
Xu, Fangzheng [1 ]
Wu, Jian [1 ]
机构
[1] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA
来源
PATHOGENS | 2023年 / 12卷 / 08期
基金
美国国家卫生研究院;
关键词
Plasmodium; genetics; genotyping; genome diversity; antigen; PLASMODIUM-FALCIPARUM MALARIA; GENETIC DIVERSITY; DRUG-RESISTANCE; MONOCLONAL-ANTIBODIES; PROTECTIVE EFFICACY; ANTIGENIC VARIATION; SELECTIVE SWEEPS; GUT MICROBIOME; SIZE VARIATION; PFSPZ VACCINE;
D O I
10.3390/pathogens12081061
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Recent advances in malaria genetics and genomics have transformed many aspects of malaria research in areas of molecular evolution, epidemiology, transmission, host-parasite interaction, drug resistance, pathogenicity, and vaccine development. Here, in addition to introducing some background information on malaria parasite biology, parasite genetics/genomics, and genotyping methods, we discuss some applications of genetic and genomic approaches in vaccine development and in studying interactions with microbiota. Genetic and genomic data can be used to search for novel vaccine targets, design an effective vaccine strategy, identify protective antigens in a whole-organism vaccine, and evaluate the efficacy of a vaccine. Microbiota has been shown to influence disease outcomes and vaccine efficacy; studying the effects of microbiota in pathogenicity and immunity may provide information for disease control. Malaria genetics and genomics will continue to contribute greatly to many fields of malaria research.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Malaria vaccine development: Progress and challenges
    Reed, ZH
    Friede, M
    Kieny, MP
    CURRENT MOLECULAR MEDICINE, 2006, 6 (02) : 231 - 246
  • [42] The problem of multiplicity in malaria vaccine development
    Mons, B
    ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1997, 91 : S55 - S58
  • [43] KINETIC CONSTRAINTS ON THE DEVELOPMENT OF A MALARIA VACCINE
    SAUL, A
    PARASITE IMMUNOLOGY, 1987, 9 (01) : 1 - 9
  • [44] COPOLYMER ADJUVANTS IN MALARIA VACCINE DEVELOPMENT
    HUNTER, RL
    LAL, AA
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1994, 50 (04): : 52 - 58
  • [45] Malaria vaccine development: persistent challenges
    Vaughan, Ashley M.
    Kappe, Stefan H. I.
    CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (03) : 324 - 331
  • [46] The development of a multivalent DNA vaccine for malaria
    Hedstrom, RC
    Doolan, DL
    Wang, RB
    Gardner, MJ
    Kumar, A
    Sedegah, M
    Gramzinski, RA
    Sacci, JB
    Charoenvit, Y
    Weiss, WR
    Margalith, M
    Norman, JA
    Hobart, P
    Hoffman, SL
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 19 (02): : 147 - 159
  • [47] Malaria vaccine development: Current status
    Engers, HD
    Godal, T
    PARASITOLOGY TODAY, 1998, 14 (02): : 56 - 64
  • [48] The Australasian contribution to malaria vaccine development
    Redmond, A. M.
    Doolan, D. L.
    PARASITE IMMUNOLOGY, 2010, 32 (08) : 607 - 622
  • [49] Advances and challenges in malaria vaccine development
    Wang, Ruobing
    Smith, Joseph D.
    Kappe, Stefan H. I.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2009, 11
  • [50] Special Issue on Malaria Vaccine Development
    Doolan, Denise L.
    HUMAN VACCINES, 2010, 6 (01): : 2 - 2